Converter Phenotype: A New Profile That Is Not Exclusive to Taxanes

Autor: Teodorikez Wilfox Jimenez-Rodriguez, Francisco Manuel Marco de la Calle, Inmaculada Lozano-Cubo, Rosa Ana Montoyo-Anton, Victor Soriano-Gomis, Purificación Gonzalez-Delgado, Amparo Burgos-San José, Seira Climent-Ballester, Natividad Martínez-Banaclocha, Javier Fernández-Sanchez

Publikováno v: Frontiers in Allergy, Vol 2 (2022)

Introduction: Phenotype I hypersensitivity reactions are the most commonly reported drug reactions; however, precision medicine has made it possible to characterize new phenotypes. A recent communication proposed the existence of a “converter pheno

Externí odkaz: https://doaj.org/article/a1070424d73c44c0b4c49ada57ad930d

Converter Phenotype: A New Profile That Is Not Exclusive to Taxanes

Autor: Teodorikez Wilfox Jimenez-Rodriguez, Francisco Manuel Marco de la Calle, Inmaculada Lozano-Cubo, Rosa Ana Montoyo-Anton, Victor Soriano-Gomis, Purificación Gonzalez-Delgado, Amparo Burgos-San José, Seira Climent-Ballester, Natividad Martínez-Banaclocha, Javier Fernández-Sanchez

Publikováno v: Frontiers in Allergy, Vol 2 (2022)

Introduction: Phenotype I hypersensitivity reactions are the most commonly reported drug reactions; however, precision medicine has made it possible to characterize new phenotypes. A recent communication proposed the existence of a “converter pheno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8340225c0d1c38c0fd264a92b805ae8b
https://pubmed.ncbi.nlm.nih.gov/35387038

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

IMPORTANCE OF MEASURING LEVELS OF INFLIXIMAB IN PATIENTS TREATING INFLAMMATORY BOWEL DISEASE IN A BRAZILIAN COHORT

Autor: Ivantes Cap, Morsoletto Dbg, Nones Rb, Loures Mr, Katia Cristina Kampa, Pissaia A

Publikováno v: Arquivos de Gastroenterologia, Iss 0 (2017)
Arquivos de Gastroenterologia v.54 n.4 2017
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE

BACKGROUND: Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases. In such pathologies, there is an increased production of alpha tumor necrosis factor (TNF-α). Patients, in whom the conventional immunosuppressant treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb3c145f4e8c54f10e071dbe14fc953
https://pubmed.ncbi.nlm.nih.gov/28954041

Converter Phenotype: A New Profile That Is Not Exclusive to Taxanes.

Autor: Jimenez-Rodriguez TW; Allergy Section, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), UMH, Alicante, Spain.; Spanish Research Network on Asthma and Adverse and Allergic Reactions (ARADyAL) Spanish Network (RD16/0006), Instituto de Salud Carlos III, Fundación Española para la Ciencia y la Tecnología, Madrid, Spain., Manuel Marco de la Calle F; Immunology Service, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Lozano-Cubo I; Oncology Section, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Montoyo-Anton RA; Oncology Day Hospital Nursing Service, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Soriano-Gomis V; Allergy Section, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), UMH, Alicante, Spain.; Spanish Research Network on Asthma and Adverse and Allergic Reactions (ARADyAL) Spanish Network (RD16/0006), Instituto de Salud Carlos III, Fundación Española para la Ciencia y la Tecnología, Madrid, Spain., Gonzalez-Delgado P; Allergy Section, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), UMH, Alicante, Spain.; Spanish Research Network on Asthma and Adverse and Allergic Reactions (ARADyAL) Spanish Network (RD16/0006), Instituto de Salud Carlos III, Fundación Española para la Ciencia y la Tecnología, Madrid, Spain., Burgos-San José A; Pharmacy Department, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Climent-Ballester S; Pharmacy Department, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Martínez-Banaclocha N; Oncology Section, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Fernández-Sanchez J; Allergy Section, Alicante General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), UMH, Alicante, Spain.; Spanish Research Network on Asthma and Adverse and Allergic Reactions (ARADyAL) Spanish Network (RD16/0006), Instituto de Salud Carlos III, Fundación Española para la Ciencia y la Tecnología, Madrid, Spain.

Publikováno v: Frontiers in allergy [Front Allergy] 2022 Jan 12; Vol. 2, pp. 785259. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2021).